KHN Editor-in-Chief Elisabeth Rosenthal appeared on to discuss the bottlenecks that have prevented doses of precious covid-19 vaccine from making it from drugmakers’ factories into patients’ arms. It didn’t have to be this way, she explains.
The independent source for health policy research, polling, and news.
KHN Editor-in-Chief Elisabeth Rosenthal appeared on to discuss the bottlenecks that have prevented doses of precious covid-19 vaccine from making it from drugmakers’ factories into patients’ arms. It didn’t have to be this way, she explains.